Global Whole Plasmid Sequencing Market Growth (Status and Outlook) 2025-2031

The global Whole Plasmid Sequencing market size is predicted to grow from US$ 78.1 million in 2025 to US$ 129 million in 2031; it is expected to grow at a CAGR of 8.7% from 2025 to 2031.

Whole plasmid sequencing is a genome sequencing service based on high-throughput sequencing technology, which is specifically used to sequence and analyze the whole genome of plasmids. Whole plasmid sequencing is mainly based on the second-generation high-throughput sequencing technology, and some service providers also provide sequencing services based on nanopore technology. Both technologies can efficiently and accurately sequence the whole genome of plasmids.

The second-generation high-throughput sequencing technology constructs a whole genome library of plasmids and sequences the library using a high-throughput sequencing platform to obtain a large amount of sequencing data. Then, bioinformatics methods are used to perform quality control, alignment, sequencing depth and coverage statistics, and sequence splicing and assembly on the sequencing data, and finally the full sequence of the plasmid is obtained.

Nanopore sequencing technology is an innovative sequencing method. Its working principle is to pass a strand of DNA through a nanoscale pore, monitor and record the current change spectrum of the nucleic acid chain passing through the nanopore in real time, and identify the characteristic current signals generated by different bases as corresponding bases, thereby reading the nucleic acid sequence. This method has the significant advantages of ultra-long read length and real-time sequencing, and can more accurately sequence complex regions such as high GC content, repetitive regions, and hairpin structures.

The rapid development of next-generation sequencing technology (NGS), such as single-cell sequencing, spatial genomics, and single-molecule sequencing, has further expanded the application scope of whole plasmid sequencing. The combination of artificial intelligence and big data analysis technology has improved the analysis efficiency and accuracy of sequencing data, providing more possibilities for scientific research and clinical applications. For example, a sequencing company has launched a sequencing data analysis platform based on deep learning algorithms, which significantly shortens the data analysis time and improves the accuracy of detection.

As an innovative sequencing technology, nanopore sequencing technology can achieve faster, more accurate, and more convenient sequencing methods. It is not affected by the size or complexity of the plasmid, and can directly measure the whole plasmid, greatly improving the success rate and accuracy of sequencing.

In the fields of precision medicine, gene editing, and synthetic biology, whole plasmid sequencing technology has become an important tool to promote innovation. With the continuous development of these fields, the demand for whole plasmid sequencing is also growing. The design defects and sequence errors of laboratory-made plasmids have also prompted scientific research institutions and enterprises to seek more accurate and efficient plasmid sequencing methods.

Whole plasmid sequencing technology is relatively mature and can realize library construction and sequencing of the whole genome of plasmids. With the development of new technologies such as nanopore sequencing, the accuracy and efficiency of whole plasmid sequencing have been further improved.

LPI (LP Information)' newest research report, the “Whole Plasmid Sequencing Industry Forecast” looks at past sales and reviews total world Whole Plasmid Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Whole Plasmid Sequencing sales for 2025 through 2031. With Whole Plasmid Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Whole Plasmid Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Whole Plasmid Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Whole Plasmid Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Whole Plasmid Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Whole Plasmid Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Whole Plasmid Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Whole Plasmid Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Plasmid Regular (2.5 – 25 kb)
Plasmid Large (25 – 125 kb)
Plasmid XL (125 – 300 kb)
Others

Segmentation by Application:
Biopharmaceutical Companies
Research Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Genomics
GenScript
Plasmidsaurus
Genewiz
Macrogen Europe
Source BioScience
Psomagen
BaseClear B.V.
Molecular Cloning Laboratories (MCLAB)
Polyplus
Elim Biopharm
SnapGene
Full Circle Labs
Unveil Bio
Microsynth AG
CD Genomics

Please note: The report will take approximately 2 business days to prepare and deliver.